Reply to Shah

The Authors’ Reply

A Further Response to Shah Ebrahim

Stacia Nordin I appreciate Zlotkin and colleagues’ years of work on the Sprinkle product, and it sounds like the product is much improved from the pill form of micronutrient treatments [1]. I’m not at all opposed to Sprinkle-type products or other nutrient pills for treatment (or in other special situations), but as ten years of international work experience on food and nutrition security issue...

The Authors’ Reply

Shah-Waardenburg Syndrome

Shah-Waardenburg syndrome (SWS) is a neurocristopathy and is characterized by Hirschsprung's disease (HD), deafness, and depigmentation of hairs, skin, and iris. Is a very rare congenital disorder with variable clinical expression. This report describes a 4-day-old male newborn with Waardenburg's syndrome associated with aganglionosis of the colon and terminal ileum, and review the relevant lit...

Reply to the Letter to the Editor Reply to

We thank Dr Schachner for his interest and comments on our recent experimental findings [1]. The first facet of our study was that although initially (at 1 month), neointima formation in vein grafts was inhibited by perivenous application of fibrin glue at the time of implantation, at 4 months neointimal formation was not significantly different from controls [1]. Dr Schachner has implied that ...